ストックスクリーナーアプリを入手
53.97
3.62%
-2.03
アフターアワーズ：
54.00
0.03
+0.06%
Tg Therapeutics Inc (TGTX) 最新ニュース
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know - Zacks Investment Research
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know - TradingView
Thermo Fisher to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research
TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis - BioSpace
TG Therapeutics (TGTX) Reports Five-Year Study Showing BRIUMVI's - GuruFocus
TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis - Business Wire
High Growth Tech Stocks To Watch In US October 2026 - Simply Wall Street
How TG’s MS Data Wave At MSToronto2026 At TG Therapeutics (TGTX) Has Changed Its Investment Story - Yahoo Finance
TG Therapeutics (TGTX) Stock May Be Undervalued Despite Fresh Newsflow - Yahoo Finance
TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 - BioSpace
TG Therapeutics (TGTX) to Present Phase 1 Azer-cel Data and BRIU - GuruFocus
TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 - Business Wire
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Singapore
TG Therapeutics (NASDAQ:TGTX) Emerges as an Affordable Growth Play in Biotech - ChartMill
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia
After tax other income/expense of TG Therapeutics, Inc. – HAN:NKB2 - TradingView
TG Therapeutics, Inc. Revenue Breakdown – HAN:NKB2 - TradingView
Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm - Morningstar
TG Therapeutics (NasdaqCM:TGTX) Stock Forecast & Analyst Predictions - Simply Wall Street
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo! Finance Canada
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup - ChartMill
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TG Therapeutics Inc (TGTX) Stock Price Today: $56.87 - Pluang
TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History - benzinga.com
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - Yahoo Finance
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - TradingView
TG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent Rebound - Yahoo Finance
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
TG Therapeutics (NASDAQ: TGTX) director plans $274,794.08 stock sale - Stock Titan
TG Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference | TGTX Stock News - quiverquant.com
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - TG Therapeutics
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com Canada
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com India
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com UK
TGTX: BRIUMVI targets $1B+ run rate, expanding with subQ and simplified dosing, backed by strong IP - TradingView
TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth - Eastern Progress
TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 24.52% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TGTX Stock On Track For Best Day In 3.5 Months Amid Fresh Buyout Rumors - Stocktwits
TG Therapeutics to Participate in the Cantor Global Healthcare Conference - manilatimes.net
TG Therapeutics to Participate in the Cantor Global Healthcare Conference - TG Therapeutics
TG Therapeutics to Participate in the Cantor Global Healthcare Conference - GlobeNewswire
B. Riley Securities Remains a Buy on TG Therapeutics (TGTX) - The Globe and Mail
(TGTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
2.87%
大文字化:
|
ボリューム (24 時間):